A systematic review of pregnancy-related clinical intervention of drug regimens due to pharmacokinetic reasons
Background and objectivePublished works have discussed the pharmacokinetic interactions of drugs with pregnancy, but none comprehensively identify all the approved United States Food and Drug Administration (FDA) and European Medicines Administration (EMA) drugs that have a pregnancy-related interve...
Main Authors: | Lauren A. Borda, Mats Någård, David W. Boulton, Raman Venkataramanan, Paola Coppola |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1241456/full |
Similar Items
-
Pharmacokinetics of obese adults: Not only an increase in weight
by: Julien Gouju, et al.
Published: (2023-10-01) -
Pharmacokinetic Monitoring of Levetiracetam in Portuguese Refractory Epileptic Patients: Effect of Gender, Weight and Concomitant Therapy
by: Rui Silva, et al.
Published: (2020-10-01) -
Lack of pharmacokinetic interaction between derazantinib and naringin in rats
by: Ya-nan Liu, et al.
Published: (2023-12-01) -
Pharmacokinetics of Toxin-Derived Peptide Drugs
by: David Stepensky
Published: (2018-11-01) -
Awareness of health care staff regarding indicated and contraindicated medication during pregnancy at Kirkuk city hospitals
by: Darya Yaseen Mustafa, et al.
Published: (2019-06-01)